Biggest stock movers today: NRIX and APLD [Seeking Alpha]
Nurix Therapeutics, Inc. - Common stock (NRIX)
Company Research
Source: Seeking Alpha
Biggest stock losers Shares of Applied Digital ( NASDAQ: APLD ) slumped 10% following disappointing FQ3 results, which fell short on both the bottom and top- lines despite revenue growth of 208% Y/Y. "During the quarter, Applied Digital encountered several challenges that impacted our financial performance due to facility power outages in our datacenter hosting business. Despite these short-term setbacks, we made significant progress with our key growth initiatives in the development of our Cloud Services business and the establishment of our special purpose built 100 MW HPC datacenter in Ellendale," stated Wes Cummins, Chairman and CEO of Applied Digital. "Other achievements included welcoming our newest Cloud Services customer, Together AI, and the strategic decision to divest our Garden City Facility." Nurix Therapeutics ( NASDAQ: NRIX ) stock fell over 8% after pricing the upsized public offering of 10.17M shares of its common stock at $15 per share, with expected gross proce
Show less
Read more
Impact Snapshot
Event Time:
NRIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NRIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NRIX alerts
High impacting Nurix Therapeutics, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
NRIX
News
- Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewswire
- Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study [Yahoo! Finance]Yahoo! Finance
- Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public OfferingGlobeNewswire
- Nurix Therapeutics Announces Proposed Public OfferingGlobeNewswire
- Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its price target raised by analysts at Royal Bank of Canada from $22.00 to $23.00. They now have an "outperform" rating on the stock.MarketBeat
NRIX
Earnings
- 4/10/24 - Beat
NRIX
Sec Filings
- 4/12/24 - Form 8-K
- 4/12/24 - Form 424B5
- 4/11/24 - Form 424B5
- NRIX's page on the SEC website